Medication info
Easy Simvastatin Tablets 10/10 mg (Ezetimibe, Simvastatin)

Easy Simvastatin Tablets 10/10 mg (Ezetimibe, Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Suhung Co., Ltd.
Appearance
White to light yellow, bi-convex, rectangular tablets
Packaging
30 tablets (10 tablets/Alu-Alu x 3)
Approval status
Active

MFDS item code 201007235 · Notified 2010.11.29 · Insurance code 679601010

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg to 10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Suhung Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia.
View approved original text

This drug is used as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia, reducing total cholesterol, LDL cholesterol, apoB protein, and triglycerides, while increasing good cholesterol, HDL cholesterol. It is particularly helpful for patients with homozygous familial hypercholesterolemia (HoFH) when alternative treatments are ineffective or difficult to implement. This drug is used for lipid control in patients with a high risk of cardiovascular disease in conjunction with dietary therapy and is recommended for those who do not respond adequately to other non-drug therapies. Before administration, it is crucial to check for secondary causes such as diabetes or hypothyroidism and treat them if necessary. During treatment, total cholesterol, LDL, HDL, and triglyceride levels should be regularly monitored, and especially when triglycerides are high, accurate LDL levels should be confirmed. This drug is used to reduce the risk of hypercholesterolemia and atherosclerotic vascular disease and improve healthy blood lipid levels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg to 10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This drug is used to lower blood cholesterol levels. While taking this drug, symptoms such as muscle pain or weakness may occur, which can lead to serious side effects such as myopathy or rhabdomyolysis. Particularly, the risk may increase when taking high doses or in combination with certain other medications, so caution is needed. Patients with impaired liver function or liver disease should not use this drug as it can worsen liver function. Women who are pregnant or nursing should not take this drug, and women who may become pregnant must consult a doctor before use. Taking this drug together with medications that inhibit certain enzymes can increase blood levels and the risk of side effects, so it is essential to inform if there are any co-administered medications. Particularly, the risk of muscle-related side effects may increase when used with antifungals, antibiotics, some cardiac medications, immunosuppressants, and fibrates. If muscle pain, muscle weakness, or unexplained muscle symptoms occur during treatment, inform a doctor immediately and discontinue the drug if necessary. Additionally, regular liver function tests and muscle enzyme tests are recommended. This drug should be used cautiously in children, especially in those under 10 years old, as safety and efficacy have not been fully established. Elderly patients may also be more sensitive to this drug, so careful monitoring is needed. Certain foods like grapefruit juice should be avoided while taking this drug, and it is important to inform healthcare providers when starting any new medications while on this drug.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, hives, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanying drug reactions, erythema multiforme, weakness, cataracts, constipation, dyspepsia, flatus, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, ocular motility disorders, facial incomplete paralysis, tremors, peripheral neuropathy, peripheral nerve paralysis, psychiatric disorders, anxiety, sleep disorders, cognitive impairment, interstitial lung disease, lupus-like syndrome, polymyalgia rheumatica, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant hepatic necrosis, liver cancer, alopecia, various skin changes, lichenoid drug rash, gynecomastia, decreased libido, sexual dysfunction, ophthalmoplegia, anemia, elevated aminotransferase levels, elevated ALP, elevated gamma-GT, elevated bilirubin levels, thyroid dysfunction, increased HbA1c, increased fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucus stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container as it is sensitive to air and moisture. It is recommended to keep it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White to light yellow, bi-convex, rectangular tablets

Package unit

30 tablets (10 tablets/Alu-Alu x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.